Finasteride Patent Expiration
Finasteride is used for treating male pattern baldness and androgenic alopecia. It was first introduced by Organon Llc A Sub Of Organon And Co
Finasteride Patents
Given below is the list of patents protecting Finasteride, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Proscar | US5942519 | Prevention of precipitated acute urinary retention |
Oct 23, 2018
(Expired) | Organon |
Propecia | US5571817 | Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones] |
Nov 05, 2013
(Expired) | Organon |
Propecia | US5547957 | Method of treating androgenic alopecia with 5-α reductase inhibitors |
Oct 15, 2013
(Expired) | Organon |
Propecia | US5886184 | Finasteride processes |
Nov 19, 2012
(Expired) | Organon |
Proscar | US5886184 | Finasteride processes |
Nov 19, 2012
(Expired) | Organon |
Finasteride's Family Patents

Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List